Monday, June 12, 2017 9:47:49 AM
I hope so. It's much better to underestimate than overestimate and fall short.
Still, the company will have to prove that it can sell the drug. We will need to actually see some revenues and contracts to get this moving.
With 6 million in revenues projected this year, I wonder what that would translate into earnings. That's going to be the key figure.
[Oh, I see she did include a slide on net income. This year shows what - maybe a million dollars? Not sure. Maybe 15 million for next year. What will that do for the share price I wonder?]
$4.7 million in debt is still on the books. Hopefully we can retire a good portion of that debt asap!
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM